- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
Chapter 4 |
109 |
Incontinence |
|
Classification 110
Causes and pathophysiology 112 Evaluation 114
Treatment of sphincter weakness incontinence: injection therapy 116
Treatment of sphincter weakness incontinence: retropubic suspension 117
Treatment of sphincter weakness incontinence: pubovaginal slings 118
Treatment of sphincter weakness incontinence: the artificial urinary sphincter 120
Overactive bladder: conventional treatment 122 Overactive bladder: options for failed conventional
therapy 124
“Mixed” incontinence 126 Post-prostatectomy incontinence 128 Vesicovaginal fistula (VVF) 130 Incontinence in the elderly patient 132
110 CHAPTER 4 Incontinence
Classification
Definition
The International Continence Society (ICS) defines incontinence as “involuntary loss of urine that is a social or hygienic problem and is objectively demonstrable.” Urinary incontinence (UI) is a failure to store urine usually due to either abnormal bladder smooth muscle or a deficient urethral sphincter. Urine loss may also be extraurethral, secondary to anatomical abnormalities such as ectopic ureter or vesicovaginal fistula.
Prevalence
UI has been reported to affect 12–43% of adult women and 3–11% of adult men. Severe incontinence has a low prevalence in young women, but rapidly increases at ages 70 through 80. Incontinence in men also increases with age, but severe incontinence in 70to 80-year-old men is about half that in women.
Classification
Stress urinary incontinence (SUI) is involuntary urinary leakage during effort, exertion, sneezing, or coughing, due to hypermobility of the bladder base, pelvic floor, and/or intrinsic urethral sphincter deficiencies. In females SUI is usually associated with multiparity. In males, SUI is most commonly the result of prostatectomy.
•Type 0—report of urinary incontinence, but without clinical signs
•Type I—leakage that occurs during stress with <2 cm descent of the bladder base below the upper border of the symphysis pubis
•Type II—leakage on stress accompanied by marked bladder base
descent (>2 cm) that occurs only during stress (IIa) or is permanently present (IIb)
•Type III—bladder neck and proximal urethra are open at rest (with or without descent). Also known as intrinsic sphincter deficiency (ISD)
Urge urinary incontinence (UUI) is involuntary urine leakage accompanied or immediately preceded by a sudden, strong desire to void (urgency).
Mixed urinary incontinence is urine leakage that has characteristics of both SUI and UUI.
Overflow incontinence is leakage of urine when the bladder is abnormally distended with large post-void residual volumes. Typically, men present with chronic urinary retention and dribbling incontinence. This can lead to hydronephrosis and renal failure in 30% of patients.
Nocturnal enuresis describes any involuntary loss of urine during sleep. The prevalence in adults is 0.5%. Approximately 750,000 children over age 7 years will regularly wet the bed. Childhood enuresis can be further classified into primary (never been dry for longer than a 6-month period) or secondary (re-emergence of bed wetting after a period of being dry for at least 6–12 months).
CLASSIFICATION 111
Post-micturition dribble is the complaint of a dribbling loss of urine that occurs after voiding. It predominantly affects males and is due to pooling of urine in the bulbous urethra after voiding. It affects approximately 20% of healthy adults1 and 60–70% of those with existent LUTS.2
1 Furuya S, Ogura H, Tanaka M, et al. (1997). Incidence of postmicturition dribble in adult males in their twenties through fifties. Hinyokika Kiyo 43(6):407–410.
2 Paterson J, Pinnock CB, Marshall VR (1997). Pelvic floor exercises as a treatment for postmicturition dribble. Br J Urol 79(6):892–897.
112 CHAPTER 4 Incontinence
Causes and pathophysiology
Risk factors
Predisposing factors
•Gender (female > males)
•Race (Caucasian > African American/Asian)
•Genetic predisposition
•Neurological disorders (spinal cord injury, stroke, MS, Parkinson disease)
•Anatomical disorders (vesicovaginal fistula, ectopic ureter, urethral diverticulum)
•Childbirth
•Anomalies in collagen subtype
•Prostate or pelvic surgery (radical prostatectomy; radical hysterectomy; TURP) leading to pelvic muscle and nerve injury
•Pelvic radiotherapy
Promoting factors
•Smoking (associated with chronic cough and raised intra-abdominal pressure)
•Obesity
•UTI
•Increased fluid intake
•Medications
•Poor nutrition
•Aging
•Cognitive deficits
•Poor mobility
Pathophysiology
Bladder abnormalities
Detrusor overactivity is a urodynamic observation characterized by involuntary bladder muscle (detrusor) contractions during the filling phase of the bladder, which may be spontaneous or provoked, and can consequently cause urinary incontinence. The underlying cause may be neurogenic, where there is a relevant neurological condition, or idiopathic, where there is no defined cause.
Low bladder compliance is characterized by a decreased volume-to-pres- sure relationship during a cystometrogram and is often associated with upper tract damage. High bladder pressures occur during filling because of alterations in the viscoelastic properties of the bladder wall, or changes in bladder muscle tone (secondary to myelodysplasia, spinal cord injury, radical hysterectomy, interstitial or radiation cystitis).
Sphincter abnormalities
Urethral hypermobility is due to a weakness of pelvic floor support causing a rotational descent of the bladder neck and proximal urethra during increases in intra-abdominal pressure. If the urethra opens concomitantly, there will be urinary leaking.
CAUSES AND PATHOPHYSIOLOGY 113
Intrinsic sphincter deficiency (ISD) describes an intrinsic malfunction of the sphincter, regardless of its anatomical position, which is responsible for type III SUI. Causes include inadequate urethral compression (previous urethral surgery; aging; menopause; radical pelvic surgery) or deficient urethral support (pelvic floor weakness; childbirth; pelvic surgery; menopause).